7
Supplementary Figure 1 a b RANK 1 2 3 4 5 6 7 8 9 10 11 * RANK Arbitrary Score ns 0 1 2 3 Normal breast Primary tumor Metastasis lymph node *

Supplementary Figure 1 a b RANK 1 2 3 4 5 6 7 8 9 10 11 * RANK Arbitrary Score ns 0 1 2 3 Normal breast Primary tumor Metastasis lymph node *

Embed Size (px)

Citation preview

Page 1: Supplementary Figure 1 a b RANK 1 2 3 4 5 6 7 8 9 10 11 * RANK Arbitrary Score ns 0 1 2 3 Normal breast Primary tumor Metastasis lymph node *

Supplementary Figure 1

a

b

RANK

1 2 3 4 5 6 7 8 9 10 11

*

RA

NK

Arb

itra

ry S

core

ns

0

1

2

3

Normal breast Primary tumor Metastasislymph node

*

Page 2: Supplementary Figure 1 a b RANK 1 2 3 4 5 6 7 8 9 10 11 * RANK Arbitrary Score ns 0 1 2 3 Normal breast Primary tumor Metastasis lymph node *

a c

d

Supplementary Figure 2

Day 3Day 1

3 H t

hym

idin

e u

pta

ke

(CP

M)

0

40000

60000

80000

100000

120000

20000

RANKL

RANKL / OPG

Control

Aniso

myc

in

Contr

ol

UV

Sorb

itol

% s

urv

ival

0

10

20

30

40

50

60 RANKLControl

RANKL Prolactin pERK1/2

pAKTAKT

pSTAT5 STAT5

0 5 10 20 40 min 5 10 20 40

pERK1/2

-Actin

ERK1/2

RANKL

0 5 10 30 60 minRANK

b

e

Page 3: Supplementary Figure 1 a b RANK 1 2 3 4 5 6 7 8 9 10 11 * RANK Arbitrary Score ns 0 1 2 3 Normal breast Primary tumor Metastasis lymph node *

Supplementary Figure 3

% in

cre

ased

mig

rati

on

RANKL [1

g/m

l]

RANKL [2

.5g/

ml]

SDF-1

[0.1g

/ml]

SDF-1 [0

.1g/

ml]

RANK

L [2.5g

/ml]

SDF-1 [1

g/m

l]

SDF-1 [1

g/m

l]

R

ANKL [2

.5g

/m]

0

20

40

60

80

100

120

Page 4: Supplementary Figure 1 a b RANK 1 2 3 4 5 6 7 8 9 10 11 * RANK Arbitrary Score ns 0 1 2 3 Normal breast Primary tumor Metastasis lymph node *

a

b c

Mig

rati

on

tow

ard

th

e ti

p, m

m

-40

0

40

80

120

160

Con

trol

RA

NK

LR

AN

KL

OPG

*

Supplementary Figure 4

Control RANKL RANKL

Control RANKL

Page 5: Supplementary Figure 1 a b RANK 1 2 3 4 5 6 7 8 9 10 11 * RANK Arbitrary Score ns 0 1 2 3 Normal breast Primary tumor Metastasis lymph node *

RANK

-actin

1 2

c

RA

NK

LR

AN

KL /

OPG

RA

NK

L / -

CX

CR

4SD

F-1

-C

XC

R4

SDF-1

O

PG

SD

F-1

10

20

30

40

50

60

70

0

% in

crea

sed

mig

rati

on

* *

Supplementary Figure 5

a

ERK1/2

RANKL SDF-1

0 3 10 30 60 120 min0 3 10 30 min

pERK1/2

d

b

0

10

20

30

40

50

60

70

80

90

100

% m

igra

tion

% in

crea

sed

mig

rati

on

20

40

60

80

100

0

SDF-

1

RA

NK

L6C

kine

6Cki

ne /

RA

NK

LC

TA

CK

CT

AC

K /

RA

NK

LSD

F-1

/ R

AN

KL

**

Page 6: Supplementary Figure 1 a b RANK 1 2 3 4 5 6 7 8 9 10 11 * RANK Arbitrary Score ns 0 1 2 3 Normal breast Primary tumor Metastasis lymph node *

Supplementary Figure 6

a c

Tibia Vertebra

Tumor Control

b

*

0

100

200

300

400

500

600

700

Total

Trabec

ular

Cortica

l

Bon

e d

ensi

ty (

pQ

CT

mg/

cm3 )

Control

B16F10

Page 7: Supplementary Figure 1 a b RANK 1 2 3 4 5 6 7 8 9 10 11 * RANK Arbitrary Score ns 0 1 2 3 Normal breast Primary tumor Metastasis lymph node *

Supplementary Figure 7

Control Tumor Tumor / OPG

**

a b c

d e f

g h i

**